The Latin America, Middle East and Africa Single-use Bioprocessing Market would witness market growth of 19.6% CAGR during the forecast period (2022-2028).
A relatively new idea in the manufacture of biopharmaceuticals is single-use bioprocessing. For administration, each and every one of the active medicinal components must be sterile. They must therefore be made in an aseptic environment. Traditional production with stainless-steel machinery is typically more expensive than single-use systems, necessitating high levels of maintenance for re-use and hence high operational costs for several years.
The great majority of biomanufacturing process steps in the facilities of biopharmaceutical businesses will undoubtedly undergo a revolution due to single-use equipment. Due to the bioprocessing technology's ability to be simplified, customized, and lower cost-of-goods, there is great potential for processes to become more cost-effective.
Coronavirus has increased awareness around the globe of the importance of a vibrant healthcare industry and the contribution that technology can make to realizing it, with the UAE and Dubai being no exception. The pharmaceutical and biomedical businesses in the area were crucial to the UAE's response to the pandemic. The United Arab Emirates' government is making a concerted effort to promote the pharmaceutical industry. The pharmaceutical business is a focus of initiatives because of its potential for future growth, export potential, and medium- to long-term economic impact.
The Brazil market dominated the LAMEA Single-use Bioprocessing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,034.7 million by 2028. The Argentina market is experiencing a CAGR of 20.2% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 19.3% during (2022 - 2028).
Based on Product, the market is segmented into Simple & Peripheral Elements (Tubing, Filters, Connectors, & Transfer Systems, Bags, Sampling Systems, Probes & Sensors [pH Sensor, Oxygen Sensor & Pressure Sensors, Temperature Sensors & Conductivity Sensors, Flow Sensors, and Others], and Others), Apparatus & Plants (Mixing, Storage, & Filling Systems, Bioreactors & Filtration System, Chromatography Systems & Pumps, and Others), and Work Equipment. Based on End-Use, the market is segmented into Biopharmaceutical Manufacturers and Academic & Clinical Research Institutes. Based on Workflow, the market is segmented into Upstream Bioprocessing, Fermentation, and Downstream Bioprocessing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Single-use Bioprocessing Market is Predict to reach $53.8 Billion by 2028, at a CAGR of 16%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Boehringer Ingelheim International GmbH, Corning Incorporated, Danaher Corporation, Eppendorf SE, Merck Millipore (Merck KGaA), Entegris, Inc., Sartorius Stedim Biotech S.A. (Sartorius AG), Thermo Fisher Scientific, Inc., and Avantor, Inc.
By Product
By End-use
By Workflow
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
